Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
- The purpose of this study is to find out if the combination of lenalidomide and radiation
therapy is effective in controlling tumor growth in patients with newly-diagnosed
supratentorial glioblastoma or gliosarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Celgene Corporation Massachusetts General Hospital University of Virginia